IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma
Clinical trial NCT03958383 · TERMINATED
Trial details
- NCT number
- NCT03958383
- Sponsor
- University of Wisconsin, Madison
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-30
- Primary completion
- 2024-01-06
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.